Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

N-acetylcysteine blocks formation of cancer-initiating estrogen-DNA adducts in cells.

Zahid M, Saeed M, Ali MF, Rogan EG, Cavalieri EL.

Free Radic Biol Med. 2010 Aug 1;49(3):392-400. doi: 10.1016/j.freeradbiomed.2010.04.028. Epub 2010 May 31.

2.

Resveratrol and N-acetylcysteine block the cancer-initiating step in MCF-10F cells.

Zahid M, Saeed M, Beseler C, Rogan EG, Cavalieri EL.

Free Radic Biol Med. 2011 Jan 1;50(1):78-85. doi: 10.1016/j.freeradbiomed.2010.10.662. Epub 2010 Oct 8.

3.
4.

Metabolism and DNA binding studies of 4-hydroxyestradiol and estradiol-3,4-quinone in vitro and in female ACI rat mammary gland in vivo.

Li KM, Todorovic R, Devanesan P, Higginbotham S, Köfeler H, Ramanathan R, Gross ML, Rogan EG, Cavalieri EL.

Carcinogenesis. 2004 Feb;25(2):289-97. Epub 2003 Oct 24.

5.

NAD(P)H:quinone oxidoreductase 1 Arg139Trp and Pro187Ser polymorphisms imbalance estrogen metabolism towards DNA adduct formation in human mammary epithelial cells.

Singh S, Zahid M, Saeed M, Gaikwad NW, Meza JL, Cavalieri EL, Rogan EG, Chakravarti D.

J Steroid Biochem Mol Biol. 2009 Oct;117(1-3):56-66. doi: 10.1016/j.jsbmb.2009.07.003. Epub 2009 Jul 21.

6.

Inhibition of depurinating estrogen-DNA adduct formation by natural compounds.

Zahid M, Gaikwad NW, Rogan EG, Cavalieri EL.

Chem Res Toxicol. 2007 Dec;20(12):1947-53. Epub 2007 Nov 27.

PMID:
18039013
7.
8.

Spectral characterization of catechol estrogen quinone (CEQ)-derived DNA adducts and their identification in human breast tissue extract.

Markushin Y, Zhong W, Cavalieri EL, Rogan EG, Small GJ, Yeung ES, Jankowiak R.

Chem Res Toxicol. 2003 Sep;16(9):1107-17.

PMID:
12971798
9.

Analysis of potential biomarkers of estrogen-initiated cancer in the urine of Syrian golden hamsters treated with 4-hydroxyestradiol.

Todorovic R, Devanesan P, Higginbotham S, Zhao J, Gross ML, Rogan EG, Cavalieri EL.

Carcinogenesis. 2001 Jun;22(6):905-11.

10.
11.

Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention.

Cavalieri E, Chakravarti D, Guttenplan J, Hart E, Ingle J, Jankowiak R, Muti P, Rogan E, Russo J, Santen R, Sutter T.

Biochim Biophys Acta. 2006 Aug;1766(1):63-78. Epub 2006 Apr 19. Review.

PMID:
16675129
12.

Formation of depurinating N3Adenine and N7Guanine adducts by MCF-10F cells cultured in the presence of 4-hydroxyestradiol.

Saeed M, Rogan E, Fernandez SV, Sheriff F, Russo J, Cavalieri E.

Int J Cancer. 2007 Apr 15;120(8):1821-4.

13.

Reduction of estrogen-induced transformation of mouse mammary epithelial cells by N-acetylcysteine.

Venugopal D, Zahid M, Mailander PC, Meza JL, Rogan EG, Cavalieri EL, Chakravarti D.

J Steroid Biochem Mol Biol. 2008 Mar;109(1-2):22-30. doi: 10.1016/j.jsbmb.2007.12.003. Epub 2007 Dec 7.

14.

Cytochrome P450 isoforms catalyze formation of catechol estrogen quinones that react with DNA.

Zhang Y, Gaikwad NW, Olson K, Zahid M, Cavalieri EL, Rogan EG.

Metabolism. 2007 Jul;56(7):887-94.

PMID:
17570247
15.

Is bisphenol A a weak carcinogen like the natural estrogens and diethylstilbestrol?

Cavalieri EL, Rogan EG.

IUBMB Life. 2010 Oct;62(10):746-51. doi: 10.1002/iub.376.

16.

Unbalanced metabolism of endogenous estrogens in the etiology and prevention of human cancer.

Cavalieri EL, Rogan EG.

J Steroid Biochem Mol Biol. 2011 Jul;125(3-5):169-80. doi: 10.1016/j.jsbmb.2011.03.008. Epub 2011 Mar 21. Review.

17.

Inhibition of catechol-O-methyltransferase increases estrogen-DNA adduct formation.

Zahid M, Saeed M, Lu F, Gaikwad N, Rogan E, Cavalieri E.

Free Radic Biol Med. 2007 Dec 1;43(11):1534-40. Epub 2007 Aug 19.

18.

Prevention of estrogen-DNA adduct formation in MCF-10F cells by resveratrol.

Zahid M, Gaikwad NW, Ali MF, Lu F, Saeed M, Yang L, Rogan EG, Cavalieri EL.

Free Radic Biol Med. 2008 Jul 15;45(2):136-45. doi: 10.1016/j.freeradbiomed.2008.03.017. Epub 2008 Apr 8.

19.
20.
Items per page

Supplemental Content

Write to the Help Desk